Transfusion independence after repeated haploidentical hematopoietic cell transplants in a patient with congenital dyserythropoietic anemia type II and hemosiderosis
AffiliationUniv Arizona, Dept Pediat
Univ Arizona, Dept Pathol
Univ Arizona, Dept Med
Univ Arizona, Dept Immunobiol
MetadataShow full item record
CitationMacaraeg M, Proytcheva M, Katsanis E. Transfusion independence after repeated haploidentical hematopoietic cell transplants in a patient with congenital dyserythropoietic anemia type II and hemosiderosis. Pediatr Transplant. 2019;00:e13587. https://doi.org/10.1111/petr.13587
RightsCopyright © 2019 Wiley Periodicals, Inc.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractMatched related or unrelated donor allogeneic HCT has occasionally been applied in patients with severe CDA type II and proven to be curative. We report on the first patient with CDA to undergo haploidentical bone marrow transplantation with PT-CY. A 12-year-old boy with severe hemosiderosis, and a, consequently, disturbed BM microenvironment, developed recurrent graft failures and required salvage with two additional haploidentical HCTs. He achieved complete donor chimerism and transfusion independence after the third HCT. Our case underscores the risks associated with performing haploidentical HCT in older pediatric patients with CDA and severe chronic iron overload.
Note12 month embargo; published online: 17 September 2019
VersionFinal accepted manuscript
- Successful Allogeneic Hematopoietic Stem Cell Transplantation of a Patient Suffering from Type II Congenital Dyserythropoietic Anemia A Rare Case Report from Western India.
- Authors: Modi G, Shah S, Madabhavi I, Panchal H, Patel A, Uparkar U, Anand A, Parikh S, Patel K, Shah K, Revannasiddaiah S
- Issue date: 2015
- T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
- Authors: Bashey A, Solomon SR
- Issue date: 2014 Aug
- Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML.
- Authors: Rashidi A, Slade M, DiPersio JF, Westervelt P, Vij R, Romee R
- Issue date: 2016 Dec
- Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload.
- Authors: Buchbinder D, Nugent D, Vu D, Soni A, Stites J, Hsieh L, Puthenveetil G
- Issue date: 2012 May
- [Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia].
- Authors: Chen HR, Lou JX, Zhang Y, Liu XD, Yang K, Chen P, Liu B, He XP, Guo Z, Liu D
- Issue date: 2012 Aug